Literature DB >> 8424997

Marfan syndrome: current and future clinical and genetic management of cardiovascular manifestations.

R E Pyeritz1.   

Abstract

Entities:  

Mesh：

Year:  1993        PMID： 8424997

Source DB:  PubMed          Journal:  Semin Thorac Cardiovasc Surg        ISSN： 1043-0679


× No keyword cloud information.
  11 in total

1.  Survival and complication free survival in Marfan's syndrome: implications of current guidelines.

Authors:  M Groenink; T A Lohuis; J G Tijssen; M S Naeff; R C Hennekam; E E van der Wall; B J Mulder
Journal:  Heart       Date:  1999-10       Impact factor: 5.994

2.  [Surgical treatment of cardiovascular manifestations of Marfan's syndrome].

Authors:  R Lange; E Ebert
Journal:  Herz       Date:  1999-12       Impact factor: 1.443

3.  Rationale and design of a randomized clinical trial of beta-blocker therapy (atenolol) versus angiotensin II receptor blocker therapy (losartan) in individuals with Marfan syndrome.

Authors:  Ronald V Lacro; Harry C Dietz; Lisa M Wruck; Timothy J Bradley; Steven D Colan; Richard B Devereux; Gloria L Klein; Jennifer S Li; L LuAnn Minich; Stephen M Paridon; Gail D Pearson; Beth F Printz; Reed E Pyeritz; Elizabeth Radojewski; Mary J Roman; J Philip Saul; Mario P Stylianou; Lynn Mahony
Journal:  Am Heart J       Date:  2007-10       Impact factor: 4.749

4.  Effect of mutation type and location on clinical outcome in 1,013 probands with Marfan syndrome or related phenotypes and FBN1 mutations: an international study.

Authors:  L Faivre; G Collod-Beroud; B L Loeys; A Child; C Binquet; E Gautier; B Callewaert; E Arbustini; K Mayer; M Arslan-Kirchner; A Kiotsekoglou; P Comeglio; N Marziliano; H C Dietz; D Halliday; C Beroud; C Bonithon-Kopp; M Claustres; C Muti; H Plauchu; P N Robinson; L C Adès; A Biggin; B Benetts; M Brett; K J Holman; J De Backer; P Coucke; U Francke; A De Paepe; G Jondeau; C Boileau
Journal:  Am J Hum Genet       Date:  2007-07-25       Impact factor: 11.025

5.  Marfan syndrome in a female collegiate basketball player: a case report.

Authors:  R Lopez; J Berg-McGraw
Journal:  J Athl Train       Date:  2000-01       Impact factor: 2.860

6.  Myocardial ischemia due to compression of an unruptured thoracic aortic aneurysm in a patient with Marfan syndrome.

Authors:  Hiroya Minami; Tatsuro Asada; Kunio Gan; Koichiro Abe; Satoshi Izumi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2007-06

7.  Clinical and mutation-type analysis from an international series of 198 probands with a pathogenic FBN1 exons 24-32 mutation.

Authors:  L Faivre; G Collod-Beroud; B Callewaert; A Child; C Binquet; E Gautier; B L Loeys; E Arbustini; K Mayer; M Arslan-Kirchner; C Stheneur; A Kiotsekoglou; P Comeglio; N Marziliano; J E Wolf; O Bouchot; P Khau-Van-Kien; C Beroud; M Claustres; C Bonithon-Kopp; P N Robinson; L Adès; J De Backer; P Coucke; U Francke; A De Paepe; G Jondeau; C Boileau
Journal:  Eur J Hum Genet       Date:  2008-11-12       Impact factor: 4.246

Review 8.  Marfan syndrome.

Authors:  Dianna M Milewicz; Alan C Braverman; Julie De Backer; Shaine A Morris; Catherine Boileau; Irene H Maumenee; Guillaume Jondeau; Arturo Evangelista; Reed E Pyeritz
Journal:  Nat Rev Dis Primers       Date:  2021-09-02       Impact factor: 65.038

9.  Deregulated microRNA and mRNA expression profiles in the peripheral blood of patients with Marfan syndrome.

Authors:  Masood Abu-Halima; Mustafa Kahraman; Dominic Henn; Tanja Rädle-Hurst; Andreas Keller; Hashim Abdul-Khaliq; Eckart Meese
Journal:  J Transl Med       Date:  2018-03-12       Impact factor: 5.531

10.  The Beneficial Effect of Renin-Angiotensin-Aldosterone System Blockade in Marfan Syndrome Patients after Aortic Root Replacement.

Authors:  Seung Jun Lee; Jaewon Oh; Young Guk Ko; Sak Lee; Byung Chul Chang; Do Yun Lee; Young Ran Kwak; Donghoon Choi
Journal:  Yonsei Med J       Date:  2016-01       Impact factor: 2.759
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.